Evidence map›Paper›PMID 36678133›Full record

ArticleNutrients2023

An Isolate of

Elliot Mathieu, Quentin Marquant, Florian Chain, Edwige Bouguyon, Vinciane Saint-Criq, Ronan Le-Goffic, Delphyne Descamps, Philippe Langella, Thomas A Tompkins, Sylvie Binda and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Clinical relevance of lung microbiota composition in critically ill children with acute lower respiratory tract infections: insights from a retrospective analysis of metagenomic sequencing.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Elliot MathieuMicalis Institute, Institut National de Recherche pour L'Agriculture, L'Alimentation et L'Environnement (INRAE), AgroParisTech, Université Paris-Saclay, UMR1319, F-78350 Jouy-en-Josas, France.
Quentin MarquantUniversité Paris-Saclay, INRAE, UVSQ, VIM, F-78350 Jouy-en-Josas, France.
Florian ChainMicalis Institute, Institut National de Recherche pour L'Agriculture, L'Alimentation et L'Environnement (INRAE), AgroParisTech, Université Paris-Saclay, UMR1319, F-78350 Jouy-en-Josas, France.
Edwige BouguyonUniversité Paris-Saclay, INRAE, UVSQ, VIM, F-78350 Jouy-en-Josas, France.
Vinciane Saint-CriqMicalis Institute, Institut National de Recherche pour L'Agriculture, L'Alimentation et L'Environnement (INRAE), AgroParisTech, Université Paris-Saclay, UMR1319, F-78350 Jouy-en-Josas, France.ORCID 0000-0003-0042-3735
Ronan Le-GofficUniversité Paris-Saclay, INRAE, UVSQ, VIM, F-78350 Jouy-en-Josas, France.ORCID 0000-0002-2012-0064
Delphyne DescampsUniversité Paris-Saclay, INRAE, UVSQ, VIM, F-78350 Jouy-en-Josas, France.ORCID 0000-0002-4883-6910
Philippe LangellaMicalis Institute, Institut National de Recherche pour L'Agriculture, L'Alimentation et L'Environnement (INRAE), AgroParisTech, Université Paris-Saclay, UMR1319, F-78350 Jouy-en-Josas, France.
Thomas A TompkinsLallemand Bio Ingredients, Montreal, QC H4P 2R2, Canada.ORCID 0000-0002-2990-2265
Sylvie BindaLallemand Health Solutions, Montreal, QC H4P 2R2, Canada.
Muriel ThomasMicalis Institute, Institut National de Recherche pour L'Agriculture, L'Alimentation et L'Environnement (INRAE), AgroParisTech, Université Paris-Saclay, UMR1319, F-78350 Jouy-en-Josas, France.ORCID 0000-0002-7608-3274
AgroParisTech · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FRLallemand (Canada) · CA

Funding

Lallemand Health Solutions (Montreal, Canada) 13001033
6 · The paper itself

Abstract

Microbiota studies have dramatically increased over these last two decades, and the repertoire of microorganisms with potential health benefits has been considerably enlarged. The development of next generation probiotics from new bacterial candidates is a long-term strategy that may be more efficient and rapid with discriminative in vitro tests.

Indexed as

PneumoniaRespiratory Tract InfectionsStaphylococcal InfectionsAnti-Bacterial AgentsBacteriaHaemophilus influenzaeHumansInfant, NewbornLungStaphylococcus aureusStreptococcus mitisAnti-Bacterial Agentsanti-microbialHaemophilus influenzae NTHiinfectioninhibitionPseudomonas aeruginosaStaphylococcus aureusStreptococcus

Identifiers

PMID36678133
PMCPMC9867278
OpenAlexW4313500432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.